| __timestamp | Sanofi | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 4667000000 | 1488000000 |
| Thursday, January 1, 2015 | 5082000000 | 1525000000 |
| Friday, January 1, 2016 | 5232000000 | 2111000000 |
| Sunday, January 1, 2017 | 5567000000 | 1848000000 |
| Monday, January 1, 2018 | 6350000000 | 1213000000 |
| Tuesday, January 1, 2019 | 6018000000 | 1010000000 |
| Wednesday, January 1, 2020 | 5529000000 | 997000000 |
| Friday, January 1, 2021 | 5692000000 | 967000000 |
| Saturday, January 1, 2022 | 6706000000 | 838000000 |
| Sunday, January 1, 2023 | 6728000000 | 953000000 |
| Monday, January 1, 2024 | 7394000000 | 998000000 |
In pursuit of knowledge
In the competitive landscape of pharmaceuticals, strategic investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, Sanofi and Teva Pharmaceutical Industries Limited have demonstrated contrasting approaches to R&D spending. From 2014 to 2023, Sanofi consistently increased its R&D expenses, peaking at approximately 6.7 billion in 2023, marking a 44% rise from 2014. In contrast, Teva's R&D spending saw a decline, dropping by 36% over the same period, from 1.5 billion in 2014 to just under 1 billion in 2023.
This divergence highlights Sanofi's commitment to innovation, potentially positioning it as a leader in pharmaceutical advancements. Meanwhile, Teva's reduced R&D investment may reflect strategic shifts or financial constraints. As the industry evolves, these investment patterns could significantly impact each company's market position and product pipeline.
Novo Nordisk A/S or Teva Pharmaceutical Industries Limited: Who Invests More in Innovation?
Analyzing R&D Budgets: Sanofi vs BeiGene, Ltd.
Who Optimizes SG&A Costs Better? Sanofi or Teva Pharmaceutical Industries Limited
R&D Spending Showdown: Sanofi vs Viatris Inc.
Research and Development: Comparing Key Metrics for Sanofi and Lantheus Holdings, Inc.
Analyzing R&D Budgets: Sanofi vs Corcept Therapeutics Incorporated
R&D Insights: How Teva Pharmaceutical Industries Limited and Neurocrine Biosciences, Inc. Allocate Funds
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Axsome Therapeutics, Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Corcept Therapeutics Incorporated
R&D Insights: How Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc. Allocate Funds
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Teva Pharmaceutical Industries Limited vs MannKind Corporation: Strategic Focus on R&D Spending